Use of age-specific normal ranges for serum prostate-specific antigen

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 4, 1998, Pages 330-332

  Slovacek, Kathleen J ^a   Riggs, Mark W ^a   Spiekerman, A Michael ^a   Speights Jr , V O ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PROSTATE ADENOCARCINOMA; STANDARD;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AGING; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 0031953165     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Crawford ED, DeAntoni EP, Etzioni R, Schaefer VC, Olson RM, Ross CA. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. Urology. 1996;47: 863-869.
2. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. JAMA. 1993;270:860-864.
3. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med. 1996;335:304-310.
4. Meshref AW, Bazinet M, Trudel C, et al. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges. Urology. 1995;45:972-979.
5. DeAntoni EP, Crawford ED. Prostate Cancer Awareness Week: education, service, and research in a community setting. Cancer. 1995;75:1874-1879.
6. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: JB Lippincott Co; 1992:181-186.
7. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration: An important clinical observation. Urol Clin North Am. 1993;20:671-680.
8. Speights VO Jr, Spiekerman AM, Brawn PN, et al. Evaluation of age-specific normal ranges for prostate-specific antigen. Urology. 1995;45:454-458.
9. Poteat HT, Ho GT, Lee M-LT, et al. The utility of patient age in evaluating prostate cancer. Am J Clin Chem. 1996;107:337-344.
10. Keetch DW, Humphrey PA. Patient age and prostate cancer. Am J Clin Chem. 1996;107:265-267. Editorial.
11. Rosen MA. Impact of prostate-specific antigen screening on the natural history of prostate cancer. Urology. 1995;46:757-768.
12. Reissigl A, Pointner J, Horninger W, et al. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study. Urology. 1995;46:662-665.
13. Catalona WJ, Hudson MA, Scardino PT, et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristics curves. J Urol. 1994;152:2037-2041.